GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CanBas Co 4575.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

689

+3.45%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−¥1.31bn

FY2017FY2026

Free cash flow

−¥1.42bn

FY2017FY2026

Shareholders' equity

¥1.64bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue————¥53.5m¥108.9m¥110.0m¥115.5m¥110.0m¥109.9m
Gross profit—−¥820.0m−¥984.0m−¥671.0m−¥608.0m−¥322.0m−¥332.0m−¥329.0m−¥314.0m−¥186.0m
Research and development¥1.06bn¥820.0m¥983.0m¥671.0m¥607.8m¥430.2m¥442.2m¥444.1m¥423.5m¥294.9m
Operating income−¥1.36bn−¥1.11bn−¥1.26bn−¥966.0m−¥846.4m−¥547.0m−¥566.4m−¥533.1m−¥539.5m−¥406.8m
Net income−¥1.31bn−¥1.16bn−¥1.21bn−¥1.24bn−¥855.6m−¥531.0m−¥572.8m−¥456.2m−¥532.1m−¥419.5m
Diluted earnings per share-66.43-58.72-63.29-69.87-56.35-57.96-78.37-66.69-93.25-76.29

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥1.78bn¥3.05bn¥2.43bn¥2.09bn¥790.7m¥1.30bn¥1.26bn¥875.4m¥578.3m¥993.3m
Cash and short-term investments¥1.45bn¥2.83bn¥1.89bn¥1.62bn¥737.8m¥1.15bn¥1.11bn¥763.7m¥466.3m¥889.4m
Total liabilities¥134.7m¥107.0m¥92.0m¥153.8m¥540.0m¥857.6m¥1.03bn¥219.1m¥156.4m¥66.2m
Debt————¥367.3m¥750.0m¥750.0m———
Shareholders' equity¥1.64bn¥2.94bn¥2.34bn¥1.93bn¥250.7m¥438.0m¥236.9m¥656.3m¥421.9m¥927.1m
Shares outstanding20m20m19m18m15m9m7m7m6m5m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥1.42bn−¥771.5m−¥1.28bn−¥1.40bn−¥719.8m−¥688.6m−¥552.9m−¥383.0m−¥429.0m−¥313.0m
Capital spending—————————−¥300,000
Free cash flow−¥1.42bn−¥771.5m−¥1.28bn−¥1.40bn−¥719.8m−¥688.6m−¥552.9m−¥383.0m−¥429.0m−¥313.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Gross profit————−¥239.0m−¥258.0m−¥147.0m−¥176.0m
Operating income−¥442.1m−¥316.0m−¥239.9m−¥360.5m−¥311.0m−¥330.0m−¥218.3m−¥250.0m
Net income−¥434.9m−¥305.0m−¥220.2m−¥348.7m−¥326.0m−¥351.7m−¥184.0m−¥296.0m
Diluted earnings per share-22.07-15.48-11.18-17.70-16.55-17.85-9.63-15.49
Total assets¥1.78bn¥2.21bn¥2.47bn¥2.67bn¥3.05bn¥2.83bn¥3.13bn¥3.78bn
Cash and short-term investments¥1.45bn¥1.77bn¥2.20bn¥2.47bn¥2.83bn¥2.60bn¥2.86bn¥3.51bn
Shareholders' equity¥1.64bn¥2.07bn¥2.38bn¥2.60bn¥2.94bn¥2.67bn¥3.02bn¥3.20bn

Financial ratios

Data as of 30 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Gross margin————-1136.9%-295.6%-301.8%-284.7%-285.5%-169.3%———
Operating margin————-1582.7%-502.1%-514.9%-461.3%-490.4%-370.3%———
Net margin————-1599.8%-487.4%-520.7%-394.8%-483.7%-381.9%———
Return on equity-79.7%-39.3%-51.6%-64.4%-341.3%-121.2%———————
Return on assets-73.7%-37.9%-49.7%-59.6%-108.2%-41.0%———————
Free cash flow yield—————————-7.2%-10.1%-7.9%-7.2%
Revenue growth————-50.9%-1.0%-4.8%5.0%0.1%4.4%———
Earnings growth13.1%-4.3%-2.8%45.4%61.1%-7.3%———————
Current ratio12.46x27.89x25.10x13.44x4.39x11.74x———————
Debt to equity———0.00x1.47x1.71x3.17x0.00x0.00x————
Equity ratio92.4%96.5%96.2%92.6%31.7%33.8%———————
Interest coverage———-826.32x-149.02x-72.90x-113.31x-627.15x—————
R&D as a share of sales————1136.4%394.9%402.0%384.3%385.0%268.5%———
Buybacks as a share of market value0.0%-3.1%-7.3%-17.3%-65.7%-25.4%———————

Growth per year

Compound annual rate

3 years5 years10 years
Operating income12.0%20.0%13.0%
Net income1.7%19.8%12.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-10.6-13.7-14.2-13.7-20.7-3.1-5.8-13.6-4.5-10.1
Price to sales————331.615.130.453.621.938.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.